Intraosseous infusion was established in 1920s as a safe and effective method of vascular access through the bone marrow. Initially, intraosseous infusion (IO) was recommended only for children less than six years of age; however, today it is administered on patients of all ages.

Currently, there are many intraosseous infusion devices available in the market for rapid administration of fluids and medications directly into the vascular systems. These devices are inserted directly into the medullary space of bone, and range from manually inserted spinal needles to the impact drivers and drill powered devices.

Various sites available for intraosseous insertion includes sternum, distal and proximal tibia, distal femur and calcaneum. The device is quickly inserted and correct placement of the device is confirmed by the flow of intravenous fluid into the device. In case extravasation of the fluid around the insertion site occurs, the device is removed to prevent development of compartment syndrome. However, aspiration of bone marrow represents another approach to confirm the correct placement of the device. One of the fastest and most reliable means of administrating the emergency fluids in the sternum is sternal intraosseous infusion (IO).

Intraosseous Infusion Devices Market: Drivers & Restraints    

Intraosseous infusion is primarily used in pre-hospital’s pediatric emergencies where intravenous delivery of fluids and medications is difficult. Increasing number of   traumatic surgeries is a key factor that’s driving the adoption of intraosseous infusion devices market. Additionally, introduction of technologically advanced intraosseous infusion devices, such as EZ-IO which allows rapid and more reliable emergency vascular access than the available manual techniques in the market, is also boosting adoption in end-use industries. Continual training of medical and nursing staff and well-defined protocols regarding proper handling of these devices is also boosting adoption in hospitals and clinics.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1569

Intraosseous infusion is safe and effective technology in case of cardiopulmonary resuscitation where other route of administration fail to deliver the required effect. Other vascular access procedures such as peripheral venous access is a time consuming procedure thus making it not feasible for cardiopulmonary resuscitation. Theintraosseous devices market is expected to grow at a healthy pace over the forecasted period.

One of the main complication while inserting the intraosseous device is extravasation of fluids and medications into soft tissues which can lead to compartment syndrome (a condition resulting from increased pressure within a confined body space). Other side effects associated with the use of these devices includes iatrogenic fractures, growth plate injury, infection (cellulitis) and osteomyelitis. These factors can impede the adoption of intraosseous infusion devices during the forecast period.

Intraosseous Infusion Devices Market: Segmentation                

Intraosseous infusion devices marketis segmented on basis of technology, route of administration, end-user, and geography:

By Technology

• Manual
• Automatic
• Impact-Driven
• Powered Drill

By Route of Administration

• Sternum
• Distal and Proximal Tibia
• Distal Femur
• Calcaneus
• Head of Humerus

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Cardiology Clinics

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1569

Intraosseous Devices Market: Region-wise Outlook

Region-wise, intraosseous devices market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan (APEJ), Japan, and Middle East and Africa. North America and Europe are the largest markets for the intraosseous device market. Launch of technologically advanced intraosseous devices by leading manufacturers and increasing incidences of various cardiac disorders are some of the factors expected to fuel the growth of these devices in the North American market. Additionally, macroeconomic factors, such as FDA approvals are also expected to increase the adoption rate of such devices in the developed countries. Key players, such as Pyng Medical Corp., are entering the Asia Pacific market by expanding its distribution network which is expected to create market opportunity for the intraosseous device market in Asia Pacific region.

Intraosseous Infusion Devices Market: Key Players

Some of the key players in the intraosseous devices market are Pyng Medical Corp., PerSys Medical, Aero Healthcare, Vidacare Corporation, Carefusion Inc., Cook Medical Inc.